Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 3 trial to evaluate the safety and efficacy of the specific immunotherapy, recombinant idiotype conjugated to KLH [keyhole limpet haemocyanin] (GTOP 99) with GM-CSF [granulocyte-macrophage colony-stimulating factors], compared to non-specific immunotherapy, KLH with GM-CSF, in patients with follicular non-Hodgkin's lymphoma

Next Previous
Trial Profile

A phase 3 trial to evaluate the safety and efficacy of the specific immunotherapy, recombinant idiotype conjugated to KLH [keyhole limpet haemocyanin] (GTOP 99) with GM-CSF [granulocyte-macrophage colony-stimulating factors], compared to non-specific immunotherapy, KLH with GM-CSF, in patients with follicular non-Hodgkin's lymphoma

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 09 May 2008

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs GTOP 99 (Primary)
  • Indications B-cell lymphoma; Follicular lymphoma
  • Focus Registrational; Therapeutic Use

    • Most Recent Events

    • 09 May 2008 Status change
    • 16 Apr 2008 Status change from in progress to completed
    • 16 Apr 2008 Results presented at AACR in 2008
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top